Learning Objectives

Review the indications and efficacy of available pharmacologic and psychotherapeutic treatment options for depression.

Faculty

Maurizio Fava, MD
Executive Vice Chair
Department of Psychiatry

Director
Depression Clinical and Research Program
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School

Accreditation

Target Audience
Psychiatrists, Primary Car Physicians, Nurse Practitioners, and Physician Assistants

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital, Massachusetts General Hospital Academy and Reed Medical Education. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

Credit Designation
McLean Hospital designates this continuing medical educational activity for a maximum of 1 AMA PRA Category 1 Credits(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Supporters
Our evidence-based curriculum is supported by an educational grant from AstraZeneca, Bristol-Myers Squibb and Lilly.

Supporters

Our evidence-based curriculum is supported by an educational grant from:

• 
  
• 
  
•